Integrated genetic and pharmacologic interrogation of rare cancers
Open Access
- 22 June 2016
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 11987
Abstract
Identifying therapeutic targets in rare cancers remains challenging due to the paucity of established models to perform preclinical studies. As a proof-of-concept, we developed a patient-derived cancer cell line, CLF-PED-015-T, from a paediatric patient with a rare undifferentiated sarcoma. Here, we confirm that this cell line recapitulates the histology and harbours the majority of the somatic genetic alterations found in a metastatic lesion isolated at first relapse. We then perform pooled CRISPR-Cas9 and RNAi loss-of-function screens and a small-molecule screen focused on druggable cancer targets. Integrating these three complementary and orthogonal methods, we identify CDK4 and XPO1 as potential therapeutic targets in this cancer, which has no known alterations in these genes. These observations establish an approach that integrates new patient-derived models, functional genomics and chemical screens to facilitate the discovery of targets in rare cancers.Keywords
This publication has 40 references indexed in Scilit:
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- C911: A Bench-Level Control for Sequence Specific siRNA Off-Target EffectsPLOS ONE, 2012
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Raise standards for preclinical cancer researchNature, 2012
- Rare cancers are not so rare: The rare cancer burden in EuropeEuropean Journal of Cancer, 2011
- ChimeraScan: a tool for identifying chimeric transcription in sequencing dataBioinformatics, 2011
- Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancerProceedings of the National Academy of Sciences, 2011
- Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53Journal of Biological Chemistry, 2009
- Highly parallel identification of essential genes in cancer cellsProceedings of the National Academy of Sciences, 2008
- Cell culture methods for the establishment of the NCI series of lung cancer cell linesJournal of Cellular Biochemistry, 1996